Format

Send to

Choose Destination
See comment in PubMed Commons below
Stem Cells Dev. 2012 Jun 10;21(9):1391-400. doi: 10.1089/scd.2011.0244. Epub 2011 Oct 18.

Adipose tissue-derived stem cells ameliorate diabetic bladder dysfunction in a type II diabetic rat model.

Author information

1
Minimally Invasive Urology Center, Provincial Hospital Affiliated to Shandong University, Jinan, China.

Abstract

Diabetes mellitus is associated with a broad constellation of voiding complaints that are often multifactorial and resistant to currently available therapies. The leading causes of diabetic bladder dysfunction (DBD) include alterations in the bladder smooth muscle, neuronal degeneration, and urothelial dysfunction. Adipose tissue-derived stem cells (ADSCs), a type of mesenchymal stromal cells, have shown promise as a novel tissue regenerative technique that may have utility in DBD. The aim of this study is to determine the efficacy and mechanism by which ADSCs may ameliorate DBD in rats fed a high-fat diet and treated with low-dose streptozotocin to induce type II diabetes. Improved voiding function was noted in ADSCs-treated rats as compared with phosphate-buffered saline-treated rats. Though some ADSCs differentiated into smooth muscle cells, paracrine pathway seems to play a main role in this process, thus resulting in reduction of apoptosis and preservation of "suburothelial capillaries network."

PMID:
22008016
PMCID:
PMC3359635
DOI:
10.1089/scd.2011.0244
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Mary Ann Liebert, Inc. Icon for PubMed Central
    Loading ...
    Support Center